Newsroom

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)

Read press release

Newsroom Highlights

Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results
  • Earnings press release
Guiding Principles for Industry Leadership: A Conversation with Agilent's CMO
  • Article
Agilent at SLAS2026
  • Conference
Agilent Ranks Among World's Best Employers
  • Award
Bringing Great Science to Life - Sustainably
  • 2024 ESG Report
Advanced Metabolomics and AI: Redefining Cell Culture Media
  • Article
Meet Our Lab Stars
  • Featured
AI is a Transformative Enabler that’s Reshaping How Science is Conducted in Labs
  • Article

Agilent News

Press Releases

More Press Releases

Media Coverage

More Media Coverage

Agilent Social Media

Agilent on LinkedIn

Agilent on Instagram

Media Coverage Highlights

Advancing GCxGC for Jet Fuel Testing: Behind the Development of ASTM D8396
  • Separation Science
Driving Sustainability Forward in Analytical Sciences
  • Technology Networks
Agilent is Fast Tracking Lab Transformation in India through Its Digital Platforms
  • BioVoice News
When Does an Instrument Become a Collaboration Partner?
  • The Analytical Scientist

Agilent Market Segment Videos

Start-to-Finish PFAS Workflows
  • Environmental
Battery Materials Analysis
  • Advanced Materials
Cancer Research Solutions
  • Cancer
Hydrogen Fuel Testing
  • Chemicals and Energy